Delaware Statutes
§ 527 — Coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome
Delaware § 527
This text of Delaware § 527 (Coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome) is published on Counsel Stack Legal Research, covering Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Del. Code tit. 31, § 527 (2026).
Text
Carriers shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome, including the use of intravenous immunoglobulin therapy in all health benefit plans delivered or issued for delivery under § 505(3) of this title.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
81 Del. Laws, c. 400, § 4
Nearby Sections
15
§ 520
Judicial review§ 5202
Execution of compact§ 5222
Supplementary agreements§ 5223
Financial arrangements§ 5226
Receipt of federal funds§ 5227
Definition§ 5228
Effective dateCite This Page — Counsel Stack
Bluebook (online)
Delaware § 527, Counsel Stack Legal Research, https://law.counselstack.com/statute/de/31/527.